Lexaria Bioscience Corp (LEXX)
2.24
+0.05
(+2.28%)
USD |
NASDAQ |
Apr 26, 10:03
Lexaria Bioscience Price: 2.24 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 2.15 | 2.30 | 2.15 | 2.19 | 22119.00 |
Apr 24, 2024 | 2.20 | 2.28 | 2.18 | 2.20 | 98910.00 |
Apr 23, 2024 | 2.24 | 2.30 | 2.20 | 2.24 | 53986.00 |
Apr 22, 2024 | 2.19 | 2.29 | 2.19 | 2.265 | 34458.00 |
Apr 19, 2024 | 2.26 | 2.29 | 2.15 | 2.20 | 61647.00 |
Apr 18, 2024 | 2.34 | 2.41 | 2.22 | 2.25 | 124708.0 |
Apr 17, 2024 | 2.30 | 2.73 | 2.25 | 2.34 | 461093.0 |
Apr 16, 2024 | 1.98 | 2.35 | 1.85 | 2.31 | 306531.0 |
Apr 15, 2024 | 2.12 | 2.14 | 1.91 | 1.99 | 315206.0 |
Apr 12, 2024 | 2.64 | 2.64 | 2.12 | 2.12 | 456031.0 |
Apr 11, 2024 | 2.60 | 2.72 | 2.50 | 2.51 | 249700.0 |
Apr 10, 2024 | 2.65 | 2.79 | 2.60 | 2.66 | 143405.0 |
Apr 09, 2024 | 3.03 | 3.03 | 2.64 | 2.70 | 246969.0 |
Apr 08, 2024 | 3.18 | 3.18 | 2.93 | 2.96 | 155258.0 |
Apr 05, 2024 | 3.12 | 3.29 | 3.05 | 3.05 | 124644.0 |
Apr 04, 2024 | 3.29 | 3.48 | 3.17 | 3.19 | 270527.0 |
Apr 03, 2024 | 3.38 | 3.569 | 3.23 | 3.41 | 246703.0 |
Apr 02, 2024 | 3.36 | 3.50 | 3.32 | 3.47 | 134543.0 |
Apr 01, 2024 | 3.82 | 3.82 | 3.25 | 3.42 | 159197.0 |
Mar 28, 2024 | 3.70 | 3.92 | 3.59 | 3.63 | 168460.0 |
Mar 27, 2024 | 3.84 | 3.91 | 3.60 | 3.71 | 232891.0 |
Mar 26, 2024 | 3.92 | 3.97 | 3.75 | 3.79 | 234292.0 |
Mar 25, 2024 | 3.46 | 4.00 | 3.400 | 3.95 | 605285.0 |
Mar 22, 2024 | 3.42 | 3.554 | 3.30 | 3.47 | 186701.0 |
Mar 21, 2024 | 3.70 | 3.96 | 3.36 | 3.44 | 848151.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6894
Minimum
May 22 2023
32.40
Maximum
Apr 26 2019
7.011
Average
5.18
Median
Price Benchmarks
Aurinia Pharmaceuticals Inc | 5.00 |
Sunshine Biopharma Inc | 0.9566 |
Acasti Pharma Inc | 2.928 |
Edesa Biotech Inc | 4.468 |
Xenon Pharmaceuticals Inc | 40.48 |
Price Related Metrics
PS Ratio | 49.86 |
Price to Book Value | 4.426 |
Earnings Yield | -30.36% |
Market Cap | 28.86M |